Apnimed, Inc. (APMD) vs Sana Biotechnology, Inc. (SANA)

A side-by-side comparison of Apnimed, Inc. and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APMD

Apnimed, Inc.

$767M

$19.27HealthcareDelayed quote: Oct 6, 2026, 1:43 PM EDT

SANA

Sana Biotechnology, Inc.

$771M

$2.77HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT

Total return — APMD vs SANA

growth of $100 · dividends reinvested · last 1y

APMD +35.9% (+35.9%/yr)SANA -12.5% (-12.5%/yr)APMD compounded faster over this window

APMD SANA

Metrics side by side

Total return (annualized)

Metric	APMD	SANA
Total return (1Y)	N/A	-27.16%
Total return CAGR (3Y)	N/A	-8.58%
Total return CAGR (5Y)	N/A	-32.33%

APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APMD analysis Full SANA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.